Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina

Molecular Vision

Volumn 19, Issue , 2013, Pages 1538-1553

  Lau, Jennifer C M ^a   Kroes, Roger A ^a   Moskal, Joseph R ^a   Linsenmeier, Robert A ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; AMPA RECEPTOR; CITRATE SODIUM; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA SYNUCLEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; STREPTOZOCIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VESICULAR GLUTAMATE TRANSPORTER 3;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LONG EVANS RAT; MUELLER CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA BLOOD VESSEL; RETINA GANGLION CELL; RETINA NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLUTAMIC ACID; PROTEIN SUBUNITS; RATS; RATS, LONG-EVANS; RECEPTORS, CELL SURFACE; RETINA; RNA, MESSENGER; STREPTOZOCIN; SYNAPTIC TRANSMISSION; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880419678     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Antonetti DA, Klein R, Gardner T W. Diabetic Retinopathy. N Engl J Med 2012; 366:1227-1239. [PMID: 22455 417].
2. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52:1156-1163. [PMID: 21357409].
3. Brandstätter JH, Koulen P, Wässle H. Diversity of glutamate receptors in the mammalian retina. Vision Res 1998; 38:1385-1397. [PMID: 9667006].
4. Santiago AR, Gaspar JM, Baptista FI, Cristovao AJ, Santos PF, Kamphuis W, Ambrosio AF. Diabetes changes the levels of ionotropic glutamate receptors in the rat retina. Mol Vis 2009; 15:1620-1630. [PMID: 19693289].
5. Ng Y-K, Zeng X-X, Ling E-A. Expression of glutamate receptors and calcium-binding proteins in the retina of strepto-zotocin-induced diabetic rats. Brain Res 2004; 1018:66-72. [PMID: 15262206].
6. Santiago AR, Hughes JM, Kamphuis W, Schlingemann RO, Ambrósio AF. Diabetes changes ionotropic glutamate receptor subunit expression level in the human retina. Brain Res 2008; 1198:153-159. [PMID: 18258217].
7. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2007; 48:5152-5159. [PMID: 17962468].
8. Lehre K P, Davanger S, Danbolt NC. Localization of the glutamate transporter protein GLAST in rat retina. Brain Res 1997; 744:129-137. [PMID: 9030421].
9. Santos MS, Li H, Voglmaier SM. Synaptic vesicle protein trafficking at the glutamate synapse. Neuroscience 2009; 158:189-203. [PMID: 18472224].
10. Gowda K, Zinnanti WJ, LaNoue KF. The influence of diabetes on glutamate metabolism in retinas. J Neurochem 2011; 117: 309-320. [PMID: 21288239].
11. Li Q, Puro DG. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 2002; 43:3109-3116. [PMID: 12202536].
12. Lieth E, Barber AJ, Xu BY, Dice C, Ratz MJ, Tanase D, Strother JM, Penn State Retina Res G. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998; 47:815-820. [PMID: 9588455].
13. Lieth E, LaNoue KF, Antonetti DA, Ratz M. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye Res 2000; 70:723-730. [PMID: 10843776].
14. Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surgu-chov A. Gamma-ynuclein as a marker of retinal ganglion cells. Mol Vis 2008; 14:1540-1548. [PMID: 18728752].
15. JM. The synucleins. Genome Biol 2002; 3:[PMID: 11806835].
16. Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB. Localization of Adenosine Receptor Messenger RNAs in the Rat Eye. Exp Eye Res 1997; 65:595-602. [PMID: 9367639].
17. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38:36-47. [PMID: 9008628].
18. Hammes H P, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998; 47:401-406. [PMID: 9519746].
19. Gilbert RE, Vranes D, Berka JL, Kelly DJ, Cox A, Wu LL, Stacker SA, Cooper ME. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998; 78:1017-1027. [PMID: 9714188].
20. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck K-H. Erythropoietin and VEGF Exhibit Equal Angiogenic Potential. Microvasc Res 2002; 64:326-333. [PMID: 12204656].
21. Hernández C, Fonollosa A, Garcia-Ramirez M, Higuera M, Catalan R, Miralles A, Garcia-Arumi J, Simo R. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006; 29:2028-2033. [PMID: 16936148].
22. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8:718-724. [PMID: 12068288].
23. Zhu B, Wang W, Gu Q, Xu X. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp Eye Res 2008; 86:375-382. [PMID: 18191124].
24. Sun Y, Jin KL, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111:1843-1851. [PMID: 12813020].
25. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP, Shima DT. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171: 53-67. [PMID: 17591953].
26. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades. Nature 2001; 412:641-647. [PMID: 11493922].
27. Guvakova MA. Insulin-like growth factors control cell migration in health and disease. Int J Biochem Cell Biol 2007; 39:890-909. [PMID: 17113337].
28. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009; 20:153-162. [PMID: 19349193].
29. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollmann R, Schatz H. Vitreous Levels of the Insulin-like Growth Factors I and II, and the Insulinlike Growth Factor Binding Proteins 2 and 3, Increase in Neovascular Eye Disease - Studies in Nondiabetic and Diabetic Subjects. J Clin Invest 1993; 92:2620-2625. [PMID: 7504689].
30. Winkler BS. A quantitative assessment of glucose metabolism in the isolated rat retina. In: Christen Y, Doly M, Droy-Lefaix M, al. e, editors. Les Seminaires ophthalmologiques d'IPSEN, Vision et adaptation. 6. Paris: Elsevier; 1995. p. 78-96.
31. Marshall OJ. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinfor-matics 2004; 20:2471-2472. [PMID: 15073005].
32. Crosson LA, Kroes RA, Moskal JR, Linsenmeier RA. Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome. Mol Vis 2009; 15:296-311. [PMID: 19204789].
33. Simpson DA, Feeney S, Boyle C, Stitt AW. Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR. Mol Vis 2000; 6:178-183. [PMID: 11023552].
34. Hastings C, Mosteller F, Tukey J W, Winsor CP. Low Moments for Small Samples: A Comparative Study of Order Statistics. Ann Math Stat 1947; 18:413-426.
35. Barnett V, Lewis T. Outliers in Statistical Data. New York: John Wiley & Sons; 1978.
36. Brandstätter JH, Hartveit E, Sassoepognetto M, Wassle H. Expression of NMDA and High-affinity Kainate Receptor Subunit mRNAs in the Adult Rat Retina. Eur J Neurosci 1994; 6:1100-1112. [PMID: 7952290].
37. Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Kohler M, Takagi T, Sakmann B, Seeburg PH. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 1990; 249:1580-1585. [PMID: 1699275].
38. Jakobs TC, Ben YX, Masland RH. Expression of mRNA for glutamate receptor subunits distinguishes the major classes of retinal neurons, but is less specific for individual cell types. Mol Vis 2007; 13:933-948. [PMID: 17653033].
39. Qin P, Pourcho RG. Immunocytochemical localization of kainate-selective glutamate receptor subunits GluR5, GluR6, and GluR7 in the cat retina. Brain Res 2001; 890:211-221. [PMID: 11164787].
40. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW, Penn State Retina Res G. Neural apoptosis in the retina during experimental and human diabetes - Early onset and effect of insulin. J Clin Invest 1998; 102:783-791. [PMID: 9710447].
41. Sugimoto M, Sasoh M, Ido M, Wakitani Y, Takahashi C, Uji Y. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica 2005; 219:379-385. [PMID: 16286799].
42. Oshitari T, Hanawa K, Adachi-Usami E. Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond) 2009; 23:884-889. [PMID: 18 437178].
43. Peng PH, Lin HS, Lin S. Nerve fibre layer thinning in patients with preclinical retinopathy. Can J Opthalmol. 2009; 44:417-422. [PMID: 19606163].
44. Park HYL, Kim IT, Park CK. Early diabetic changes in the nerve fibre layer at the macula detected by spectral domain optical coherence tomography. Br J Ophthalmol 2011; 95:1223-1228. [PMID: 21216799].
45. van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Verbraak FD, Abràmoff MD. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50:3404-3409. [PMID: 19151397].
46. van Dijk HW, Kok PHB, Garvin M, Sonka M, DeVries JH, Michels RPJ, van Velthoven MEJ, Schlingemann RO, Verbraak FD, Abramoff MD. Selective Loss of Inner Retinal Layer Thickness in Type 1 Diabetic Patients with Minimal Diabetic Retinopathy. Invest Ophthalmol Vis Sci 2009; 50:3404-3409. [PMID: 19151397].
47. van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, Devries JH, Michels R P, van Velthoven ME, Schlinge-mann RO, Abràmoff MD. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010; 51:3660-3665. [PMID: 20130282].
48. van Dijk HW, Verbraak FD, Stehouwer M, Kok PHB, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abramoff MD. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res 2011; 51:224-228. [PMID: 20801146].
49. van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abràmoff MD. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 2012; 53:2715-2719. [PMID: 22427582].
50. Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 2001; 24:107-129. [PMID: 118 31548].
51. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res 1997; 37:3483-3493. [PMID: 9425525].
52. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010; 460:525-542. [PMID: 20229265].
53. Gong J, Jellali A, Mutterer J, Sahel JA, Rendon A, Picaud S. Distribution of vesicular glutamate transporters in rat and human retina. Brain Res 2006; 1082:73-85. [PMID: 16516863].
54. Baptista FI, Gaspar JM, Cristóvão A, Santos PF, Köfalvi A, Ambrósio A F. Diabetes induces early transient changes in the content of vesicular transporters and no major effects in neurotransmitter release in hippocampus and retina. Brain Res 2011; 1383:257-269. [PMID: 21281613].
55. Semkova I, Huemmeke M, Ho MS, Merkl B, Abari E, Paulsson M, Joussen AM, Plomann M. Retinal localization of the glutamate receptor GluR2 and GluR2-regulating proteins in diabetic rats. Exp Eye Res 2010; 90:244-253. [PMID: 19878674].
56. Hartwick AT, Lalonde MR, Barnes S, Baldridge WH. Adenosine A1-receptor modulation of glutamate-induced calcium influx in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45:3740-3748. [PMID: 15452085].
57. Aung MH, Kim MK, Olson DE, Thule PM, Pardue MT. Early visual deficits in streptozotocin-induced diabetic long evans rats. Invest Ophthalmol Vis Sci 2013; 54:1370-1377. [PMID: 23372054].
58. Schrufer TL, Antonetti DA, Sonenberg N, Kimball SR, Gardner TW, Jefferson LS. Ablation of 4E-BP1/2 Prevents Hyperglycemia-Mediated Induction of VEGF Expression in the Rodent Retina and in Muller Cells in Culture. Diabetes 2010; 59:2107-2116. [PMID: 20547975].
59. Kirwin SJ, Kanaly ST, Linke NA, Edelman JL. Strain-Dependent Increases in Retinal Inflammatory Proteins and Photoreceptor FGF-2 Expression in Streptozotocin-Induced Diabetic Rats. Invest Ophthalmol Vis Sci 2009; 50:5396-5404. [PMID: 19474406].
60. Brucklacher RM, Patel KM, VanGuilder HD, Bixler GV, Barber AJ, Antonetti DA, Lin CM, LaNoue K F, Gardner TW, Bronson SK, Freeman WM. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovas-cular inflammatory response. BMC Med Genomics 2008; 1:26 [PMID: 18554398].
61. Takagi H, Watanabe D, Suzuma K, Kurimoto M, Suzuma I, Ohashi H, Ojima T, Murakami T. Novel role of erythropoi-etin in proliferative diabetic retinopathy. Diabetes Res Clin Pract 2007; 77:Supplement 1S62-1S64. [PMID: 17481772].
62. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinop-athy. N Engl J Med 2005; 353:782-792. [PMID: 16120858].
63. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: Direct neuroprotective effect in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242-10247. [PMID: 10963684].
64. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002; 99:10659-10664. [PMID: 12130665].
65. Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis A P. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 2004; 165:457-469. [PMID: 15277220].
66. Smith LEH, Shen W, Perruzzi C, Soker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999; 5:1390-1395. [PMID: 10581081].
67. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR. Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 2003; 111:1835-1842. [PMID: 12813019].
68. Delafontaine P, Song YH, Li Y. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 2004; 24:435-444. [PMID: 14 6 0 4834].
69. Russo VC, Gluckman PD, Feldman EL, Werther GA. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 2005; 26:916-943. [PMID: 16131630].
70. Jogie-Brahim S, Feldman D, Oh Y. Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease. Endocr Rev 2009; 30:417-437. [PMID: 19477944].
71. Yamada PM, Lee KW. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 2009; 296:C954-C976. [PMID: 19279229].
72. Kirwin SJ, Kanaly ST, Hansen CR, Cairns BJ, Ren M, Edelman JL. Retinal gene expression and visually evoked behavior in diabetic long evans rats. Invest Ophthalmol Vis Sci 2011; 52:7654-7663. [PMID: 218 62641].
73. Lofqvist C, Chen J, Connor KM, Smith ACH, Aderman CM, Liu N, Pintar JE, Ludwig T, Hellstrom A, Smith LEH. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. National Academy of Sciences. 2007;104:10589-10594.
74. Kielczewski JL, Hu P, Shaw LC, Calzi SL, Mames RN, Gardiner TA, McFarland E, Chan-Ling T, Grant MB. Novel Protective Properties of IGFBP-3 Result in Enhanced Pericyte Ensheathment, Reduced Microglial Activation, Increased Microglial Apoptosis, and Neuronal Protection after Ischemic Retinal Injury. Am J Pathol 2011; 178:1517-1528. [PMID: [PMID: 21435441].